-
1
-
-
36849027817
-
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
-
Hu C.Y., Rodriguez-Pinto D., Du W., Ahuja A., Henegariu O., Wong F.S., et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007, 117:3857-3867.
-
(2007)
J Clin Invest
, vol.117
, pp. 3857-3867
-
-
Hu, C.Y.1
Rodriguez-Pinto, D.2
Du, W.3
Ahuja, A.4
Henegariu, O.5
Wong, F.S.6
-
2
-
-
43049171493
-
B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions
-
Xiu Y., Wong C.P., Bouaziz J.D., Hamaguchi Y., Wang Y., Pop S.M., et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 2008, 180:2863-2875.
-
(2008)
J Immunol
, vol.180
, pp. 2863-2875
-
-
Xiu, Y.1
Wong, C.P.2
Bouaziz, J.D.3
Hamaguchi, Y.4
Wang, Y.5
Pop, S.M.6
-
3
-
-
70449480577
-
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
-
Pescovitz M.D., Greenbaum C.J., Krause-Steinrauf H., Becker D.J., Gitelman S.E., Goland R., et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009, 361:2143-2152.
-
(2009)
N Engl J Med
, vol.361
, pp. 2143-2152
-
-
Pescovitz, M.D.1
Greenbaum, C.J.2
Krause-Steinrauf, H.3
Becker, D.J.4
Gitelman, S.E.5
Goland, R.6
-
4
-
-
72249122333
-
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1
-
Orban T., Sosenko J.M., Cuthbertson D., Krischer J.P., Skyler J.S., Jackson R., et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care 2009, 32:2269-2274.
-
(2009)
Diabetes Care
, vol.32
, pp. 2269-2274
-
-
Orban, T.1
Sosenko, J.M.2
Cuthbertson, D.3
Krischer, J.P.4
Skyler, J.S.5
Jackson, R.6
-
5
-
-
0031738116
-
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
-
Verge C.F., Stenger D., Bonifacio E., Colman P.G., Pilcher C., Bingley P.J., et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998, 47:1857-1866.
-
(1998)
Diabetes
, vol.47
, pp. 1857-1866
-
-
Verge, C.F.1
Stenger, D.2
Bonifacio, E.3
Colman, P.G.4
Pilcher, C.5
Bingley, P.J.6
-
6
-
-
0032145276
-
B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice
-
Falcone M., Lee J., Patstone G., Yeung B., Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998, 161:1163-1168.
-
(1998)
J Immunol
, vol.161
, pp. 1163-1168
-
-
Falcone, M.1
Lee, J.2
Patstone, G.3
Yeung, B.4
Sarvetnick, N.5
-
7
-
-
0035887763
-
Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice
-
Greeley S.A., Moore D.J., Noorchashm H., Noto L.E., Rostami S.Y., Schlachterman A., et al. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol 2001, 167:4351-4357.
-
(2001)
J Immunol
, vol.167
, pp. 4351-4357
-
-
Greeley, S.A.1
Moore, D.J.2
Noorchashm, H.3
Noto, L.E.4
Rostami, S.Y.5
Schlachterman, A.6
-
8
-
-
0032532294
-
B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice
-
Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998, 161:3912-3918.
-
(1998)
J Immunol
, vol.161
, pp. 3912-3918
-
-
Serreze, D.V.1
Fleming, S.A.2
Chapman, H.D.3
Richard, S.D.4
Leiter, E.H.5
Tisch, R.M.6
-
9
-
-
0036918641
-
The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors
-
Silveira P.A., Johnson E., Chapman H.D., Bui T., Tisch R.M., Serreze D.V. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 2002, 32:3657-3666.
-
(2002)
Eur J Immunol
, vol.32
, pp. 3657-3666
-
-
Silveira, P.A.1
Johnson, E.2
Chapman, H.D.3
Bui, T.4
Tisch, R.M.5
Serreze, D.V.6
-
10
-
-
0035879105
-
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice
-
Tian J., Zekzer D., Hanssen L., Lu Y., Olcott A., Kaufman D.L. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001, 167:1081-1089.
-
(2001)
J Immunol
, vol.167
, pp. 1081-1089
-
-
Tian, J.1
Zekzer, D.2
Hanssen, L.3
Lu, Y.4
Olcott, A.5
Kaufman, D.L.6
-
11
-
-
0034568991
-
Reciprocal regulation of polarized cytokine production by effector B and T cells
-
Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482.
-
(2000)
Nat Immunol
, vol.1
, pp. 475-482
-
-
Harris, D.P.1
Haynes, L.2
Sayles, P.C.3
Duso, D.K.4
Eaton, S.M.5
Lepak, N.M.6
-
12
-
-
0029826977
-
B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new speed congenic stock of NOD.Ig mu null mice
-
Serreze D.V., Chapman H.D., Varnum D.S., Hanson M.S., Reifsnyder P.C., Richard S.D., et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new speed congenic stock of NOD.Ig mu null mice. J Exp Med 1996, 184:2049-2053.
-
(1996)
J Exp Med
, vol.184
, pp. 2049-2053
-
-
Serreze, D.V.1
Chapman, H.D.2
Varnum, D.S.3
Hanson, M.S.4
Reifsnyder, P.C.5
Richard, S.D.6
-
13
-
-
79959687704
-
Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igmu(null) mice after polyclonal B cell reconstitution
-
Vong A.M., Daneshjou N., Norori P.Y., Sheng H., Braciak T.A., Sercarz E.E., et al. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igmu(null) mice after polyclonal B cell reconstitution. J Transl Med 2011, 9:101.
-
(2011)
J Transl Med
, vol.9
, pp. 101
-
-
Vong, A.M.1
Daneshjou, N.2
Norori, P.Y.3
Sheng, H.4
Braciak, T.A.5
Sercarz, E.E.6
-
14
-
-
0030969531
-
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice
-
Noorchashm H., Noorchashm N., Kern J., Rostami S.Y., Barker C.F., Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997, 46:941-946.
-
(1997)
Diabetes
, vol.46
, pp. 941-946
-
-
Noorchashm, H.1
Noorchashm, N.2
Kern, J.3
Rostami, S.Y.4
Barker, C.F.5
Naji, A.6
-
15
-
-
0035889964
-
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice
-
Hulbert C., Riseili B., Rojas M., Thomas J.W. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol 2001, 167:5535-5538.
-
(2001)
J Immunol
, vol.167
, pp. 5535-5538
-
-
Hulbert, C.1
Riseili, B.2
Rojas, M.3
Thomas, J.W.4
-
16
-
-
0031170911
-
Development of insulitis and diabetes in B cell-deficient NOD mice
-
Yang M., Charlton B., Gautam A.M. Development of insulitis and diabetes in B cell-deficient NOD mice. J Autoimmun 1997, 10:257-260.
-
(1997)
J Autoimmun
, vol.10
, pp. 257-260
-
-
Yang, M.1
Charlton, B.2
Gautam, A.M.3
-
17
-
-
0030022742
-
Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells
-
Peterson J.D., Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 1996, 45:328-336.
-
(1996)
Diabetes
, vol.45
, pp. 328-336
-
-
Peterson, J.D.1
Haskins, K.2
-
18
-
-
0035807589
-
Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency
-
Martin S., Wolf-Eichbaum D., Duinkerken G., Scherbaum W.A., Kolb H., Noordzij J.G., et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001, 345:1036-1040.
-
(2001)
N Engl J Med
, vol.345
, pp. 1036-1040
-
-
Martin, S.1
Wolf-Eichbaum, D.2
Duinkerken, G.3
Scherbaum, W.A.4
Kolb, H.5
Noordzij, J.G.6
-
19
-
-
32044473550
-
Genotype/phenotype correlations in X-linked agammaglobulinemia
-
Broides A., Yang W., Conley M.E. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 2006, 118:195-200.
-
(2006)
Clin Immunol
, vol.118
, pp. 195-200
-
-
Broides, A.1
Yang, W.2
Conley, M.E.3
-
20
-
-
34547193611
-
B-cell anergy: from transgenic models to naturally occurring anergic B cells
-
Cambier J.C., Gauld S.B., Merrell K.T., Vilen B.J. B-cell anergy: from transgenic models to naturally occurring anergic B cells. Nat Rev Immunol 2007, 7:633-643.
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 633-643
-
-
Cambier, J.C.1
Gauld, S.B.2
Merrell, K.T.3
Vilen, B.J.4
-
21
-
-
33646136685
-
Silencing of autoreactive B cells by anergy: a fresh perspective
-
Gauld S.B., Merrell K.T., Cambier J.C. Silencing of autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol 2006, 18:292-297.
-
(2006)
Curr Opin Immunol
, vol.18
, pp. 292-297
-
-
Gauld, S.B.1
Merrell, K.T.2
Cambier, J.C.3
-
22
-
-
0023729241
-
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
-
Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
-
(1988)
Nature
, vol.334
, pp. 676-682
-
-
Goodnow, C.C.1
Crosbie, J.2
Adelstein, S.3
Lavoie, T.B.4
Smith-Gill, S.J.5
Brink, R.A.6
-
23
-
-
27544458293
-
Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling
-
Gauld S.B., Benschop R.J., Merrell K.T., Cambier J.C. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol 2005, 6:1160-1167.
-
(2005)
Nat Immunol
, vol.6
, pp. 1160-1167
-
-
Gauld, S.B.1
Benschop, R.J.2
Merrell, K.T.3
Cambier, J.C.4
-
24
-
-
1842476272
-
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice
-
Silveira P.A., Dombrowsky J., Johnson E., Chapman H.D., Nemazee D., Serreze D.V. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol 2004, 172:5086-5094.
-
(2004)
J Immunol
, vol.172
, pp. 5086-5094
-
-
Silveira, P.A.1
Dombrowsky, J.2
Johnson, E.3
Chapman, H.D.4
Nemazee, D.5
Serreze, D.V.6
-
25
-
-
78649603355
-
Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice
-
Cox S.L., Stolp J., Hallahan N.L., Counotte J., Zhang W., Serreze D.V., et al. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice. Eur J Immunol 2010, 40:3413-3425.
-
(2010)
Eur J Immunol
, vol.40
, pp. 3413-3425
-
-
Cox, S.L.1
Stolp, J.2
Hallahan, N.L.3
Counotte, J.4
Zhang, W.5
Serreze, D.V.6
-
26
-
-
17044400224
-
The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11
-
Rolf J., Motta V., Duarte N., Lundholm M., Berntman E., Bergman M.L., et al. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol 2005, 174:4821-4827.
-
(2005)
J Immunol
, vol.174
, pp. 4821-4827
-
-
Rolf, J.1
Motta, V.2
Duarte, N.3
Lundholm, M.4
Berntman, E.5
Bergman, M.L.6
-
27
-
-
0033977135
-
Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice
-
Wither J.E., Roy V., Brennan L.A. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice. Clin Immunol 2000, 94:51-63.
-
(2000)
Clin Immunol
, vol.94
, pp. 51-63
-
-
Wither, J.E.1
Roy, V.2
Brennan, L.A.3
-
28
-
-
0035013708
-
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
-
Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
-
(2001)
Immunity
, vol.14
, pp. 617-629
-
-
Martin, F.1
Oliver, A.M.2
Kearney, J.F.3
-
29
-
-
1642536499
-
Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells
-
Attanavanich K., Kearney J.F. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004, 172:803-811.
-
(2004)
J Immunol
, vol.172
, pp. 803-811
-
-
Attanavanich, K.1
Kearney, J.F.2
-
30
-
-
84887992705
-
The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development
-
Ziegler A.I., Le Page M.A., Maxwell M.J., Stolp J., Guo H., Jayasimhan A., et al. The CD19 signalling molecule is elevated in NOD mice and controls type 1 diabetes development. Diabetologia 2013, 56:2659-2668.
-
(2013)
Diabetologia
, vol.56
, pp. 2659-2668
-
-
Ziegler, A.I.1
Le Page, M.A.2
Maxwell, M.J.3
Stolp, J.4
Guo, H.5
Jayasimhan, A.6
-
31
-
-
0030784484
-
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes
-
Inaoki M., Sato S., Weintraub B.C., Goodnow C.C., Tedder T.F. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997, 186:1923-1931.
-
(1997)
J Exp Med
, vol.186
, pp. 1923-1931
-
-
Inaoki, M.1
Sato, S.2
Weintraub, B.C.3
Goodnow, C.C.4
Tedder, T.F.5
-
32
-
-
0036116272
-
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
-
Greeley S.A., Katsumata M., Yu L., Eisenbarth G.S., Moore D.J., Goodarzi H., et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002, 8:399-402.
-
(2002)
Nat Med
, vol.8
, pp. 399-402
-
-
Greeley, S.A.1
Katsumata, M.2
Yu, L.3
Eisenbarth, G.S.4
Moore, D.J.5
Goodarzi, H.6
-
33
-
-
4644225746
-
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse
-
Wong F.S., Wen L., Tang M., Ramanathan M., Visintin I., Daugherty J., et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004, 53:2581-2587.
-
(2004)
Diabetes
, vol.53
, pp. 2581-2587
-
-
Wong, F.S.1
Wen, L.2
Tang, M.3
Ramanathan, M.4
Visintin, I.5
Daugherty, J.6
-
34
-
-
80052834728
-
Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells
-
Silva D.G., Daley S.R., Hogan J., Lee S.K., Teh C.E., Hu D.Y., et al. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 2011, 60:2102-2111.
-
(2011)
Diabetes
, vol.60
, pp. 2102-2111
-
-
Silva, D.G.1
Daley, S.R.2
Hogan, J.3
Lee, S.K.4
Teh, C.E.5
Hu, D.Y.6
-
35
-
-
0033564970
-
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice
-
Noorchashm H., Lieu Y.K., Noorchashm N., Rostami S.Y., Greeley S.A., Schlachterman A., et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999, 163:743-750.
-
(1999)
J Immunol
, vol.163
, pp. 743-750
-
-
Noorchashm, H.1
Lieu, Y.K.2
Noorchashm, N.3
Rostami, S.Y.4
Greeley, S.A.5
Schlachterman, A.6
-
36
-
-
84868008849
-
B-cell cross-presentation of autologous antigen precipitates diabetes
-
Marino E., Tan B., Binge L., Mackay C.R., Grey S.T. B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 2012, 61:2893-2905.
-
(2012)
Diabetes
, vol.61
, pp. 2893-2905
-
-
Marino, E.1
Tan, B.2
Binge, L.3
Mackay, C.R.4
Grey, S.T.5
-
37
-
-
11844290756
-
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis
-
Hussain S., Delovitch T.L. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol 2005, 174:680-687.
-
(2005)
J Immunol
, vol.174
, pp. 680-687
-
-
Hussain, S.1
Delovitch, T.L.2
-
38
-
-
16244396427
-
The stages of type 1A diabetes: 2005
-
Gianani R., Eisenbarth G.S. The stages of type 1A diabetes: 2005. Immunol Rev 2005, 204:232-249.
-
(2005)
Immunol Rev
, vol.204
, pp. 232-249
-
-
Gianani, R.1
Eisenbarth, G.S.2
-
39
-
-
84856689949
-
Development of autoantibodies in the TrialNet Natural History Study
-
Vehik K., Beam C.A., Mahon J.L., Schatz D.A., Haller M.J., Sosenko J.M., et al. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care 2011.
-
(2011)
Diabetes Care
-
-
Vehik, K.1
Beam, C.A.2
Mahon, J.L.3
Schatz, D.A.4
Haller, M.J.5
Sosenko, J.M.6
-
40
-
-
0035511862
-
International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice
-
Bonifacio E., Atkinson M., Eisenbarth G., Serreze D., Kay T.W., Lee-Chan E., et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001, 50:2451-2458.
-
(2001)
Diabetes
, vol.50
, pp. 2451-2458
-
-
Bonifacio, E.1
Atkinson, M.2
Eisenbarth, G.3
Serreze, D.4
Kay, T.W.5
Lee-Chan, E.6
-
41
-
-
0034652317
-
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes
-
Yu L., Robles D.T., Abiru N., Kaur P., Rewers M., Kelemen K., et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000, 97:1701-1706.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 1701-1706
-
-
Yu, L.1
Robles, D.T.2
Abiru, N.3
Kaur, P.4
Rewers, M.5
Kelemen, K.6
-
42
-
-
84874885423
-
Tolerant anti-insulin B cells are effective APCs
-
Kendall P.L., Case J.B., Sullivan A.M., Holderness J.S., Wells K.S., Liu E., et al. Tolerant anti-insulin B cells are effective APCs. J Immunol 2013, 190:2519-2526.
-
(2013)
J Immunol
, vol.190
, pp. 2519-2526
-
-
Kendall, P.L.1
Case, J.B.2
Sullivan, A.M.3
Holderness, J.S.4
Wells, K.S.5
Liu, E.6
-
43
-
-
76949098835
-
Chromogranin A is an autoantigen in type 1 diabetes
-
Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
-
(2010)
Nat Immunol
, vol.11
, pp. 225-231
-
-
Stadinski, B.D.1
Delong, T.2
Reisdorph, N.3
Reisdorph, R.4
Powell, R.L.5
Armstrong, M.6
-
44
-
-
80052880827
-
Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells
-
Delong T., Baker R.L., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., et al. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes 2011, 60:2325-2330.
-
(2011)
Diabetes
, vol.60
, pp. 2325-2330
-
-
Delong, T.1
Baker, R.L.2
Reisdorph, N.3
Reisdorph, R.4
Powell, R.L.5
Armstrong, M.6
-
45
-
-
58149359257
-
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes
-
Fiorina P., Vergani A., Dada S., Jurewicz M., Wong M., Law K., et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes 2008, 57:3013-3024.
-
(2008)
Diabetes
, vol.57
, pp. 3013-3024
-
-
Fiorina, P.1
Vergani, A.2
Dada, S.3
Jurewicz, M.4
Wong, M.5
Law, K.6
-
46
-
-
67650272801
-
CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells
-
Marino E., Villanueva J., Walters S., Liuwantara D., Mackay F., Grey S.T. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells. Diabetes 2009, 58:1568-1577.
-
(2009)
Diabetes
, vol.58
, pp. 1568-1577
-
-
Marino, E.1
Villanueva, J.2
Walters, S.3
Liuwantara, D.4
Mackay, F.5
Grey, S.T.6
-
47
-
-
71849093408
-
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice
-
Zekavat G., Rostami S.Y., Badkerhanian A., Parsons R.F., Koeberlein B., Yu M., et al. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol 2008, 181:8133-8144.
-
(2008)
J Immunol
, vol.181
, pp. 8133-8144
-
-
Zekavat, G.1
Rostami, S.Y.2
Badkerhanian, A.3
Parsons, R.F.4
Koeberlein, B.5
Yu, M.6
-
48
-
-
80755168884
-
Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies
-
Serreze D.V., Chapman H.D., Niens M., Dunn R., Kehry M.R., Driver J.P., et al. Loss of intra-islet CD20 expression may complicate efficacy of B-cell-directed type 1 diabetes therapies. Diabetes 2011, 60:2914-2921.
-
(2011)
Diabetes
, vol.60
, pp. 2914-2921
-
-
Serreze, D.V.1
Chapman, H.D.2
Niens, M.3
Dunn, R.4
Kehry, M.R.5
Driver, J.P.6
-
49
-
-
29344460633
-
The therapeutic potential of anti-CD20 what do B-cells do?
-
Eisenberg R., Looney R.J. The therapeutic potential of anti-CD20 what do B-cells do?. Clin Immunol 2005, 117:207-213.
-
(2005)
Clin Immunol
, vol.117
, pp. 207-213
-
-
Eisenberg, R.1
Looney, R.J.2
-
50
-
-
58149464696
-
A review of the current use of rituximab in autoimmune diseases
-
Gurcan H.M., Keskin D.B., Stern J.N., Nitzberg M.A., Shekhani H., Ahmed A.R. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009, 9:10-25.
-
(2009)
Int Immunopharmacol
, vol.9
, pp. 10-25
-
-
Gurcan, H.M.1
Keskin, D.B.2
Stern, J.N.3
Nitzberg, M.A.4
Shekhani, H.5
Ahmed, A.R.6
-
51
-
-
36749011882
-
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
-
Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007, 104:17040-17045.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 17040-17045
-
-
Wenzlau, J.M.1
Juhl, K.2
Yu, L.3
Moua, O.4
Sarkar, S.A.5
Gottlieb, P.6
-
52
-
-
0142061950
-
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence
-
Williams A.J., Norcross A.J., Dix R.J., Gillespie K.M., Gale E.A., Bingley P.J. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia 2003, 46:1354-1356.
-
(2003)
Diabetologia
, vol.46
, pp. 1354-1356
-
-
Williams, A.J.1
Norcross, A.J.2
Dix, R.J.3
Gillespie, K.M.4
Gale, E.A.5
Bingley, P.J.6
-
53
-
-
0023722804
-
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age
-
Vardi P., Ziegler A.G., Mathews J.H., Dib S., Keller R.J., Ricker A.T., et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 1988, 11:736-739.
-
(1988)
Diabetes Care
, vol.11
, pp. 736-739
-
-
Vardi, P.1
Ziegler, A.G.2
Mathews, J.H.3
Dib, S.4
Keller, R.J.5
Ricker, A.T.6
-
54
-
-
18744385526
-
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope
-
Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224-228.
-
(2005)
Nature
, vol.435
, pp. 224-228
-
-
Kent, S.C.1
Chen, Y.2
Bregoli, L.3
Clemmings, S.M.4
Kenyon, N.S.5
Ricordi, C.6
-
55
-
-
42449144715
-
HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families
-
Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
-
(2008)
Diabetes
, vol.57
, pp. 1084-1092
-
-
Erlich, H.1
Valdes, A.M.2
Noble, J.3
Carlson, J.A.4
Varney, M.5
Concannon, P.6
-
56
-
-
58149299735
-
Analysis of islet inflammation in human type 1 diabetes
-
Willcox A., Richardson S.J., Bone A.J., Foulis A.K., Morgan N.G. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009, 155:173-181.
-
(2009)
Clin Exp Immunol
, vol.155
, pp. 173-181
-
-
Willcox, A.1
Richardson, S.J.2
Bone, A.J.3
Foulis, A.K.4
Morgan, N.G.5
-
57
-
-
59649105484
-
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes
-
Panigrahi A.K., Goodman N.G., Eisenberg R.A., Rickels M.R., Naji A., Luning Prak E.T. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med 2008, 205:2985-2994.
-
(2008)
J Exp Med
, vol.205
, pp. 2985-2994
-
-
Panigrahi, A.K.1
Goodman, N.G.2
Eisenberg, R.A.3
Rickels, M.R.4
Naji, A.5
Luning Prak, E.T.6
-
58
-
-
84877115482
-
A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models
-
Dai X., James R.G., Habib T., Singh S., Jackson S., Khim S., et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest 2013, 123:2024-2036.
-
(2013)
J Clin Invest
, vol.123
, pp. 2024-2036
-
-
Dai, X.1
James, R.G.2
Habib, T.3
Singh, S.4
Jackson, S.5
Khim, S.6
-
59
-
-
84855369247
-
Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant
-
Habib T., Funk A., Rieck M., Brahmandam A., Dai X., Panigrahi A.K., et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol 2012, 188:487-496.
-
(2012)
J Immunol
, vol.188
, pp. 487-496
-
-
Habib, T.1
Funk, A.2
Rieck, M.3
Brahmandam, A.4
Dai, X.5
Panigrahi, A.K.6
-
60
-
-
60549091762
-
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors
-
Duty J.A., Szodoray P., Zheng N.Y., Koelsch K.A., Zhang Q., Swiatkowski M., et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 2009, 206:139-151.
-
(2009)
J Exp Med
, vol.206
, pp. 139-151
-
-
Duty, J.A.1
Szodoray, P.2
Zheng, N.Y.3
Koelsch, K.A.4
Zhang, Q.5
Swiatkowski, M.6
-
61
-
-
34047142747
-
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs
-
Popa C., Leandro M.J., Cambridge G., Edwards J.C. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology (Oxford) 2007, 46:626-630.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 626-630
-
-
Popa, C.1
Leandro, M.J.2
Cambridge, G.3
Edwards, J.C.4
|